Research Presentation Sessions: Oncologic Imaging
RPS 1816 - Genito-urinary tumours
Lectures
1
Introduction by the moderator
02:00Davide Prezzi, London / UK
2
Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases
08:00Ricardo Donners, Basel / CH
3
Hyperpolarised 13C-pyruvate MRI as a non-invasive read-out of tumour grade in renal cell carcinoma
08:00Stephan Ursprung, Tübingen / DE
4
Early reduction in spectral dual-layer detector CT parameters as favourable imaging biomarkers in patients with metastatic renal cell carcinoma
08:00Aska Drljevic-Nielsen, Aarhus N / DK
5
Evaluation of immunotherapy response with CT histogram analysis in metastatic Renal Cell Carcinoma
08:00Sıla Cankaya, Ankara / TR
6
Validation of PI-RADS v2 for detection of prostate cancer among readers with different degree of experience using US/MRI fusion guided prostate biopsy as reference standard
08:00Jinxing Yu, Richmond / US
7
The estimated volume index (EVI); a new practical approach for treatment response monitoring in advanced ovarian cancer patients treated with neoadjuvant chemotherapy
08:00Eva Berardi, roma / IT
8
CT radiomic based models to predict residual disease and early recurrence in primary debulked ovarian cancer
08:00Gregorio Aluffi, Verona / IT
9
Histogram analysis for characterisation of indeterminate adrenal nodules
08:00Abdellatif Masmoudi, tunis / TN
